Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 241 AL 255

Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials

Yasar S, Schuchman M, Peters J, Anstey KJ, Carlson MC, Peters R.

Curr Hypertens Rep. 2016 Aug;18(8):67. doi: 10.1007/s11906-016-0674-1.

Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects

De Beaumont L, Pelleieux S, Lamarre-Théroux L, Dea D, Poirier J; Alzheimer’s Disease Cooperative Study.

J Alzheimers Dis. 2016 Oct 4;54(3):913-922. doi: 10.3233/JAD-160373.

Drug use in persons with and without Alzheimer's disease aged 90 years or more

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Age Ageing. 2016 Nov;45(6):900-904. doi: 10.1093/ageing/afw141. Epub 2016 Sep 8.

Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders

Sandoval-Hernández A, Contreras MJ, Jaramillo J, Arboleda G.

Adv Exp Med Biol. 2016;949:287-310. doi: 10.1007/978-3-319-40764-7_14.

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease

Cavedo E, Dubois B, Colliot O, Lista S, Croisile B, Tisserand GL, Touchon J, Bonafe A, Ousset PJ, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Galluzzi S, Delmaire C, Ceccaldi M, Girard N, Lehericy S, Duveau F, Chupin M, Sarazin M, Dormont D, Hampel H; Hippocampus Study Group.

J Clin Psychiatry. 2016 Dec;77(12):e1631-e1638. doi: 10.4088/JCP.15m10413.

Calcium-Channel Blockers and Dementia Risk in Older Adults - National Health Insurance Service - Senior Cohort (2002-2013)

Hwang D, Kim S, Choi H, Oh IH, Kim BS, Choi HR, Kim SY, Won CW.

Circ J. 2016 Oct 25;80(11):2336-2342. doi: 10.1253/circj.CJ-16-0692. Epub 2016 Sep 21.

Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study

Boccardi M, Altomare D, Ferrari C, Festari C, Guerra UP, Paghera B, Pizzocaro C, Lussignoli G, Geroldi C, Zanetti O, Cotelli MS, Turla M, Borroni B, Rozzini L, Mirabile D, Defanti C, Gennuso M, Prelle A, Gentile S, Morandi A, Vollaro S, Volta GD, Bianchetti A, Conti MZ, Cappuccio M, Carbone P, Bellandi D, Abruzzi L, Bettoni L, Villani D, Raimondi MC, Lanari A, Ciccone A, Facchi E, Di Fazio I, Rozzini R, Boffelli S, Manzoni L, Salvi GP, Cavaliere S, Belotti G, Avanzi S, Pasqualetti P, Muscio C, Padovani A, Frisoni GB; Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Working Group.

JAMA Neurol. 2016 Dec 1;73(12):1417-1424. doi: 10.1001/jamaneurol.2016.3751.

The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease

Grizzanti J, Lee HG, Camins A, Pallas M, Casadesus G.

Nutr Res. 2016 Dec;36(12):1305-1315. doi: 10.1016/j.nutres.2016.11.002. Epub 2016 Nov 8.

Editorial (Thematic Issue: Endocrine Disorders and Cognitive Function in the Elderly)

Pasqualetti G, Calsolaro V, Monzani F.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):2-3. doi: 10.2174/187221481001161005181628.

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease

Kwakowsky A, Milne MR, Waldvogel HJ, Faull RL.

Int J Mol Sci. 2016 Dec 17;17(12):2122. doi: 10.3390/ijms17122122.

Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease

Pierrot N, Lhommel R, Quenon L, Hanseeuw B, Dricot L, Sindic C, Maloteaux JM, Octavea JN, Ivanoiu A.

J Alzheimers Dis. 2016;49(2):271-6. doi: 10.3233/JAD-150405.

Alzheimer's disease: the amyloid hypothesis on trial

Harrison JR, Owen MJ.

Br J Psychiatry. 2016 Jan;208(1):1-3. doi: 10.1192/bjp.bp.115.167569.

Oxidative challenge in Alzheimer's disease: state of knowledge and future needs

Cervellati C, Wood PL, Romani A, Valacchi G, Squerzanti M, Sanz JM, Ortolani B, Zuliani G.

J Investig Med. 2016 Jan;64(1):21-32. doi: 10.1136/jim-2015-000017.

Rethinking on the concept of biomarkers in preclinical Alzheimer's disease

Berti V, Polito C, Lombardi G, Ferrari C, Sorbi S, Pupi A.

Neurol Sci. 2016 May;37(5):663-72. doi: 10.1007/s10072-016-2477-1. Epub 2016 Jan 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias